Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
Many people are concerned about the state of their immunity and strive to support it. However, when asking how to strengthen the immune system, not everyone understands where this «immunity» is located or what it consists of. So, here’s a quick overview.
Subscribe to mailing and get the latest news and discounts of our store.>
The effect of short peptides on brain functioning under normal and neurodegenerative conditions
Dear Friends!
We are pleased to introduce you a new scientific lecture devoted to the study of peptide bioregulators in a convenient video format. This time our latest lecture from our series of research articles of Scientific Information Centre is devoted to the topic — «The effect of short peptides on brain functioning under normal and neurodegenerative conditions».
The lecture explores the effects of peptide bioregulators on the central nervous system. The following aspects of peptide bioregulation in neurodegenerative diseases are discussed:
- mechanisms of action of peptides
- impact of peptides on cognitive functions, memory and learning processes
- influence on recovery after traumas and neurodegenerative diseases
The lecture will be interesting and useful for specialists in medicine, biology and pharmacology, as well as for anyone interested in neuroscience research and exploration of effective treatments for neurodegenerative diseases.
The scientific lecture is prepared by Anastasia Ilina:
- Research assistant of the Laboratory of Molecular Mechanisms of Ageing, Saint-Petersburg Institute of Bioregulation and Gerontology
- Ph.D candidate in the Department of Pathology and Pathophysiology of Institute of Experimental Medicine
We invite you to dive into the world of peptides: you will find out how they affect the brain in a healthy state and in neurodegenerative processes in our new video lecture.
We wish you a pleasant viewing experience!
Peptides celebrates 6 years in Europe!
We are proud to celebrate this important milestone, which is the result of the diligence and dedication of our partners.
We are excited to introduce you brand new complex geroprotectors of a new type based on peptide extracts - GPL® Man and GPL® Femme - created as long joint ventures between Peptides and Saint-Petersburg Institute of bioregulation and gerontology.
The leading task of bioregulation is activating the processes of elimination of toxins from the body. A new product “Cleantestin”, developed by the Peptides company, is the embodiment of this idea.
